Author:
Anerao A.,Patil B,Jaguste R,Pradhan N.,
Abstract
Methyl iodide has been highlighted as a potential genotoxic impurity (PGI). A sensitive HS-GC method with ECD was developed and validated for the determination of methyl iodide impurity in Tedizolid phosphate, an active pharmaceutical ingredient. HS-GC method on DB-624,column 60m X 0.53mm, film thickness 3μm, with electron capture detector (ECD) was used. The proposed method was specific, linear, accurate, rugged and precise. The calibration curves showed good linearity over the concentration range of 0.78 μg/g to 11.7 μg/g and the correlation coefficient was 0.997. Method had very low limit of detection (LOD) and limits of quantification (LOQ) are 0.23 μg/g and 0.78 μg/g, respectively, with respect to test concentration. Accuracy was observed within the range 96.0% to 103.2%. This method is a further extended good quality control tool for low level quantitation of methyl iodide impurity in another API, alogliptin benzoate.
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference18 articles.
1. [1] European Medicines Agency; Assessment report; Sivextro; Procedure No. EMEA/H/C/002846; 2015.
2. [2] U. S. Food and Drug Administration; Application number: 205435; https://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/anti-infectivedrugsadvisorycommittee/ucm390790.pdf; Accessed March 31st, 2014.
3. [3] Acute exposure guideline levels (AEGLS) for methyl iodide- National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances- (NAC/AEGL Committee) NAC Proposed 1: November 2009
4. [4] Methyl iodide; IARC MONOGRAPHS; VOLUME 71; Supplement 7; 1987; 1503-1510.
5. [5] Impurities in new drug substances Q3A (R2); International conference on harmonization of technical requirements for registration of pharmaceuticals for human use; October 2006.